Bevacizumab
(+ FOLFOX, CAPOX, FOLFIRI, FOLFOXIRI)
Pembrolizumab (MSI high oder dMMR)
RAS-Wt:
Cetuximab (+ FOLFOX, FOLFIRI)
Panitumumab (+ FOLFOX, FOLFIRI)
Aflibercept (+ FOLFIRI)
Bevacizumab
Encorafenib + Cetuximab (V600E-Mt)
Nivolumab + Ipilimumab (dMMR, MSI high)
Ramucirumab (+ FOLFIRI)
Regorafenib (3L)